GSK — GSK plcToday's name, from the SEC's present-day ticker list — a present-day mapping, not the name as of each filing.

Congress trades
79
all time
Members · 12m
1
1 buys · 2 sells · by trade date
Latest filing
11-21
2025-11-21
Rows filed past the STOCK Act's 45-day window, stated on the row, never editorialised; both dates and the receipt stay on every row.
15
13F holders
731
top 500 listed · 2026-03-31
Congress: statutory ranges, filed up to 45 days after the trade · 13F: quarter-end snapshots, filed up to 45 days lateras of 2026-10-29
Congress 79Institutional 500

Congress · disclosure timeline

By trade date · 24 months · 12 rows ▲ buy, ▼ sell; height = lower bound (log scale). Trade date, not filing date — the filing lag is in the table below.

12 dated disclosures in the window, placed by trade date; magnitudes are the disclosed lower bounds, against gridlines at $15K, $250K, $5M.

Members active in GSK

12 months · most active first Rows = number of disclosures, not dollars. Net = lower bound of the net range. Committees as of each member's latest trade in the window (roster snapshot 2026-10-29).
Members disclosing GSK in the trailing 12 months
MemberRowsNet disclosed flow for this ticker: purchases minus sales, computed as a net range on the disclosed amounts. A lower bound is provable, never a point.Number of committees the member sat on as of their latest trade date in the window, from the cc0-legislators roster snapshot. Context, never an allegation; jurisdiction overlap needs the sector join.
Lisa C. McClain R–MI-93−$29.0K to $13.0K2

1 member

Congressional disclosures

Newest filed firstAll 79 rows ↗
Latest congressional filings mentioning GSK
FiledMemberSide · OwnerTraded · LagAmountRange · FlagsSrc
2025-11-21Lisa C. McClain R–MI-9SELL SP (spouse-owned)Traded 10-31 +21d$1K–$15K
2025-11-21Lisa C. McClain R–MI-9BUY SP (spouse-owned)Traded 10-30 +22d$1K–$15K
2025-11-21Lisa C. McClain R–MI-9SELL SP (spouse-owned)Traded 10-30 +22d$1K–$15K
2025-10-10Val T. Hoyle D–OR-4SELL SP (spouse-owned)Traded 09-23 +17d$1K–$15K
2025-09-12Lisa C. McClain R–MI-9BUY SP (spouse-owned)Traded 08-04 +39d$1K–$15K
2025-09-12Val T. Hoyle D–OR-4BUY SP (spouse-owned)Traded 2024-11-18 LATE·298d$1K–$15K
2025-09-10Robert B. Aderholt R–AL-4SELLTraded 07-28 +44d$1K–$15K
2025-08-13Lisa C. McClain R–MI-9SELL SP (spouse-owned)Traded 06-24 LATE·50d$1K–$15K
2025-08-13Lisa C. McClain R–MI-9BUY SP (spouse-owned)Traded 06-17 LATE·57d$1K–$15K
2025-05-12Bruce Westerman R–AR-4SELLTraded 04-21 +21d$1K–$15K

13F holders · Quarter ended 2026-03-31Newest filing in this build: 2026-07-31. Per-row filing dates are on each receipt. · longs only

All holders ↗
Top institutional holders of GSK for quarter 2026-03-31, 1–25 of 731 holders
#FilerValueSecuritiesFlagsderived by Public Filings from this build's reviewed ticker-mapping holders list for this share class; that list carries each holder's share count, share change and filed date (the full holders view shows them), but no document links — the EDGAR link opens the filer's 13F list·§
1FMR LLC$3.7B1
derived ·§ EDGAR ↗
2DODGE & COX$3.2B1
derived ·§ EDGAR ↗
3PRIMECAP MANAGEMENT CO/CA/$1.4B1
derived ·§ EDGAR ↗
4WELLINGTON MANAGEMENT GROUP LLP$647M1
derived ·§ EDGAR ↗
5MORGAN STANLEY$609M1
derived ·§ EDGAR ↗
6ROYAL BANK OF CANADA$414M1
derived ·§ EDGAR ↗
7STATE STREET CORP$334M1
derived ·§ EDGAR ↗
8Holocene Advisors, LP$305M1
derived ·§ EDGAR ↗
9BANK OF MONTREAL /CAN/$256M1
derived ·§ EDGAR ↗
10BlackRock, Inc.$196M1
derived ·§ EDGAR ↗
11Grantham, Mayo, Van Otterloo & Co. LLC$194M1
derived ·§ EDGAR ↗
12HOTCHKIS & WILEY CAPITAL MANAGEMENT LLC$192M1
derived ·§ EDGAR ↗
13EQUITY INVESTMENT CORP$178M1
derived ·§ EDGAR ↗
14Connor, Clark & Lunn Investment Management Ltd.$155M1
derived ·§ EDGAR ↗
15DIMENSIONAL FUND ADVISORS LP$143M1
derived ·§ EDGAR ↗
16MANUFACTURERS LIFE INSURANCE COMPANY, THE$131M1
derived ·§ EDGAR ↗
17SEI INVESTMENTS CO$126M1
derived ·§ EDGAR ↗
18BANK OF AMERICA CORP /DE/$122M1
derived ·§ EDGAR ↗
19UBS Group AG$115M1
derived ·§ EDGAR ↗
20ENVESTNET ASSET MANAGEMENT INC$101M1
derived ·§ EDGAR ↗
21Eversept Partners, LP$98.5M1
derived ·§ EDGAR ↗
22NORTHERN TRUST CORP$96.5M1
derived ·§ EDGAR ↗
23LETKO, BROSSEAU & ASSOCIATES INC$90.8M1
derived ·§ EDGAR ↗
24ARROWSTREET CAPITAL, LIMITED PARTNERSHIP$89.5M1
derived ·§ EDGAR ↗
25AMERICAN CENTURY COMPANIES INC$89.2M1
derived ·§ EDGAR ↗
Show the top 500 of 731 holders
Truncated by Public Filings. Top 500 of 731 holders shown; the rest are on EDGAR. Method ↗

Crowding — not available in this build. No holder rows for the selected period, so no percentile can be ranked.

Congress ↔ notable managers · GSK

Congress · last 90 days

Buyers
0 — —
Sellers
0 — —

filed 2026-07-31 → 2026-10-29 · statutory ranges

Notable managers · quarter ended 2026-03-31

Adding
0 — $0 held
Trimming
1 Bridgewater Associates $38.6M held

by shares · $ = value heldNEW + ADD vs TRIM + EXIT, by share count. $ = reported value now, not the change. · GSK PLC

Merged timeline of congressional filings and notable-manager moves on GSK
DateWhoChangeSize
2026-05-15Bridgewater Associates 13FTRIM−717,859 sh

1 newest, by filing date · 13F rows are quarter-end snapshots, not trades

Congress vs filers

12 months
Congress net (rows)1 buy / 2 sell
Congress net ($ bound)−$29.0K to $13.0K
Filersnot computedThe filer side needs per-issuer quarter-over-quarter actions, which the published aggregate does not carry for this issuer. Convergence and divergence are stated only when both sides are computed.